Drug use among transgender people in Ontario, Canada: Disparities and associations with social exclusion
Drug use among transgender people in Ontario, Canada: Disparities and associations with social exclusion
复制标题
DOI：
10.1016/j.addbeh.2017.03.022
复制
发表时间：
2017-09-01
影响因子：
4.4
通讯作者：
Shokoohi, Mostafa
中科院分区：
文献类型：
--
作者：
Scheim, Ayden I.;Bauer, Greta R.;Shokoohi, Mostafa
介绍：我们确定了加拿大安大略省变性人过去一年非法药物使用的流行率和相关性，以及与年龄标准化的非变性人的差距。方法：16岁以上变性人(n=406)的数据来自受访者驱动抽样(RDS)调查(2009-2010)。参考人群中过去一年药物使用(可卡因和安非他明，基于数据可获得性)的总体和性别估计是从加拿大社区健康调查(2009-2010年)中16岁以上的安大略省居民(n=39980)获得的，并根据总体和性别特定的变性人年龄分布进行标准化。在使用TransPulse数据的回归分析中，过去一年的药物使用包括与对使用者的身体、心理和社会伤害的高风险相关的药物类型，RDS-II权重被应用于从区块Logistic回归模型得出的频率和患病率(PR)。结果：估计12.3%(95%CI：7.7，17.0)的变性人在过去一年中至少使用过一种指定的药物，性别认同没有显著差异。与年龄标准化的非变性人群相比，安大略省变性人更有可能同时使用可卡因(标准化患病率差异；SPD=6.8%；95%CI=1.6，10.9)和苯丙胺(SPD=SPD=1.3%，95%CI=0.2，3.1)。变性人的恐惧症、无家可归或住房不足以及性工作与变性人中更多的药物使用有关。结论：加拿大安大略省变性人中可卡因和安非他命的使用率高于年龄标准化参考人群。社会排斥预测变性人中药物使用的群体内差异。
Introduction: We identified the prevalence and correlates of past-year illicit drug use among transgender people in Ontario, Canada, and disparities with the age-standardized non-transgender population.Methods: Data on transgender persons aged 16 + (n = 406) were obtained from Trans PULSE, a respondent driven sampling (RDS) survey (2009-2010). Overall and sex-specific estimates of past-year drug use (cocaine and amphetamines, based on data availability) in the reference population were obtained from Ontario residents aged 16 + (n = 39, 980) in the Canadian Community Health Survey (2009-2010), and standardized to the overall and gender-specific transgender age distributions. For regression analyses with Trans PULSE data, past year drug use included drug types associated with high risk of physical, psychological, and social harm to the user, and RDS-II weights were applied to frequencies and prevalence ratios (PR) derived from blockwise logistic regression models.Results: An estimated 12.3% (95% CI: 7.7, 17.0) of transgender Ontarians had used at least one of the specified drugs in the past year, with no significant difference by gender identity. Transgender Ontarians were more likely to use both cocaine (standardized prevalence difference; SPD = 6.8%; 95% CI = 1.6, 10.9) and amphetamines (SPD = SPD = 1.3%, 95% CI = 0.2, 3.1) as compared to the age-standardized non-transgender population. History of transphobic assault, homelessness or underhousing, and sex work were associated with greater drug use among transgender persons.Conclusions: The prevalence of cocaine and amphetaihine use among transgender people in Ontario, Canada was higher than in the age-standardized reference population. Social exclusion predicted within-group variation in drug use among transgender persons.